Evidence map›Paper›PMID 42738348›Full record

ReviewCancers2026

Rethinking Immunotherapy Resistance in Melanoma: A Narrative Review of Clinical Patterns, Resistance Mechanisms, and Future Strategies.

Ali Ghais, Joe Rizkallah, Bahaa El Deen Wehbeh, Youssef Diab, Ali Awada, Mostafa Atwi, Rama Ayoub, Carine Mina, Firas Rammal, Aya Badr and 3 more

Abstract readReview
In one paragraph

Review in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Ali GhaisDepartment of Internal Medicine, Virginia Commonwealth University, Richmond, VA 23298, USA.ORCID 0009-0002-7254-4261
Joe RizkallahDivision of Hematology and Oncology, Department of Internal Medicine, American University of Beirut, Beirut P.O. Box 11-0236, Lebanon.ORCID 0000-0001-9053-5866
Bahaa El Deen WehbehDivision of Hematology and Oncology, Department of Internal Medicine, American University of Beirut, Beirut P.O. Box 11-0236, Lebanon.ORCID 0009-0005-7446-4312
Youssef DiabDivision of Hematology and Oncology, Department of Internal Medicine, American University of Beirut, Beirut P.O. Box 11-0236, Lebanon.ORCID 0009-0000-8588-9053
Ali AwadaDivision of Hematology and Oncology, Department of Internal Medicine, American University of Beirut, Beirut P.O. Box 11-0236, Lebanon.
Mostafa AtwiDivision of Hematology and Oncology, Department of Internal Medicine, American University of Beirut, Beirut P.O. Box 11-0236, Lebanon.
Rama AyoubDivision of Hematology and Oncology, Department of Internal Medicine, American University of Beirut, Beirut P.O. Box 11-0236, Lebanon.
Carine MinaDivision of Hematology and Oncology, Department of Internal Medicine, American University of Beirut, Beirut P.O. Box 11-0236, Lebanon.
Firas RammalDivision of Hematology and Oncology, Department of Internal Medicine, American University of Beirut, Beirut P.O. Box 11-0236, Lebanon.ORCID 0009-0005-6131-0955
Aya BadrDivision of Hematology and Oncology, Department of Internal Medicine, American University of Beirut, Beirut P.O. Box 11-0236, Lebanon.ORCID 0009-0003-9758-5323
Sary FarajDivision of Hematology and Oncology, Department of Internal Medicine, American University of Beirut, Beirut P.O. Box 11-0236, Lebanon.ORCID 0000-0003-4857-8365
Nicole CharbelDivision of Hematology and Oncology, Department of Internal Medicine, American University of Beirut, Beirut P.O. Box 11-0236, Lebanon.ORCID 0009-0004-7877-3086
Firas KreidiehDivision of Hematology and Oncology, Department of Internal Medicine, American University of Beirut, Beirut P.O. Box 11-0236, Lebanon.ORCID 0000-0003-2751-5154

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

acquired resistanceimmune checkpoint inhibitorsimmunotherapy resistancemelanomaprimary resistancetumor microenvironment

Identifiers

PMID42738348
PMCPMC13565487

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.